MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts

di Honorat, Mylène, Guitton, Jérôme, Gauthier, Charlotte, Bouard, Charlotte, Lecerf-Schmidt, Florine, Peres, Basile, Terreux, Raphaël, Gervot, Héloïse, Rioufol, Catherine, Boumendjel, Ahcène, Puisieux, Alain, Di Pietro, Attilio, Payen, Léa
Pubblicato in Oncotarget (2015)

ELLIPSE Study: A Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia

di Dupuis-Girod, Sophie, Ambrun, Alexis, Decullier, Evelyne, Samson, Géraldine, Roux, Adeline, Fargeton, Anne-Emmanuelle, Rioufol, Catherine, Schwiertz, Verane, Disant, François, Chapuis, François, Donazzolo, Yves, Paintaud, Gilles, Edery, Patrick, Faure, Frederic
Pubblicazione 2014

Adherence to oral anticancer chemotherapy: What influences patients’ over or non-adherence? Analysis of the OCTO study through quantitative–qualitative methods

di Bourmaud, Aurélie, Henin, Emilie, Tinquaut, Fabien, Regnier, Véronique, Hamant, Chloé, Colomban, Olivier, You, Benoit, Ranchon, Florence, Guitton, Jérôme, Girard, Pascal, Freyer, Gilles, Tod, Michel, Rioufol, Catherine, Trillet-Lenoir, Véronique, Chauvin, Franck
Pubblicato in BMC Res Notes (2015)

Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs

di Ranchon, Florence, Salles, Gilles, Späth, Hans-Martin, Schwiertz, Vérane, Vantard, Nicolas, Parat, Stéphanie, Broussais, Florence, You, Benoît, Tartas, Sophie, Souquet, Pierre Jean, Dussart, Claude, Falandry, Claire, Henin, Emilie, Freyer, Gilles, Rioufol, Catherine
Pubblicazione 2011

Conditions for the Implementation of a Patient Education Program Dedicated to Cancer Patients Treated by Oral Anticancer Therapy

di Verot, Elise, Falandry, Claire, Régnier Denois, Véronique, Feutrier, Corinne, Chapoton, Boris, Okala, Jean, Pupier, Sidonie, Rousset, Vanessa, Bridet, Françoise, Ravot, Christine, Rioufol, Catherine, Trillet-Lenoir, Véronique, Hureau, Magali, Chauvin, Franck, Bourmaud, Aurélie
Pubblicato in Patient Prefer Adherence (2020)

Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)()

di Slimano, Florian, Baudouin, Amandine, Zerbit, Jérémie, Toulemonde-Deldicque, Anne, Thomas-Schoemann, Audrey, Chevrier, Régine, Daouphars, Mikaël, Madelaine, Isabelle, Pourroy, Bertrand, Tournamille, Jean-François, Astier, Alain, Ranchon, Florence, Cazin, Jean-Louis, Bardin, Christophe, Rioufol, Catherine
Pubblicato in Cancer Treat Rev (2020)

Hypersensitivity to oxaliplatin: clinical features and risk factors

di Parel, Marie, Ranchon, Florence, Nosbaum, Audrey, You, Benoit, Vantard, Nicolas, Schwiertz, Vérane, Gourc, Chloé, Gauthier, Noémie, Guedat, Marie-Gabrielle, He, Sophie, Kiouris, Eléna, Alloux, Céline, Vial, Thierry, Trillet-Lenoir, Véronique, Freyer, Gilles, Berard, Frédéric, Rioufol, Catherine
Pubblicazione 2014

Immunomodulatory drugs in multiple myeloma: Impact of the SCARMET (Self CARe and MEdication Toxicity) educational intervention on outpatients’ knowledge to manage adverse effects

di Périchou, Juliette, Ranchon, Florence, Herledan, Chloé, Huot, Laure, Larbre, Virginie, Carpentier, Isabelle, Lazareth, Anne, Karlin, Lionel, Beny, Karen, Vantard, Nicolas, Schwiertz, Vérane, Caffin, Anne Gaelle, Baudouin, Amandine, Sesques, Pierre, Brisou, Gabriel, Ghesquières, Hervé, Salles, Gilles, Rioufol, Catherine
Pubblicato in PLoS One (2020)